Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Sensitive Combined Assay Detects Multiple Viruses

By LabMedica International staff writers
Posted on 16 Feb 2012
A combination assay has been developed that identifies several European Arboviruses that cause aseptic meningoencephalitis or febrile disease.

A combined multiplex ligation-dependent probe amplification and flow-through microarray assay was devised for the detection of European Bunyaviruses.

Scientists at the University Medical Center (Göttingen, Germany) decided to try an amplification and hybridization approach, which amplifies a synthetic signal molecule, which is dependent on sequence-specific hybridization rather than an amplification technique that amplifies the target molecule itself. More...
Their methodology combines multiplex ligation-dependent probe amplification (MLPA) with a flow-through chip hybridization system.

The authors developed the assay based on the combination of real time-MLPA (RT-MPLA) and flow-through three-dimensional (3D) universal microarray for the detection of seven European Bunyaviruses, for an expanded accurate diagnosis of aseptic meningoencephalitis and fevers of unknown origin in Europe. The viruses studied were Toscana virus, (TOSV), sand fly fever Sicilian virus (SFSV), sand fly fever Naples virus (SFNV), mosquito-borne Tahyna virus (TAHV), Inkoo virus (INKV), Batai virus (BATV) and tick-borne Uukuniemi virus (UUKV).

Reagents for MLPA and RT-MLPA were obtained from MRC-Holland (Amsterdam, The Netherlands) and the flow-through chip hybridization system was acquired from PamGene ('s-Hertogenbosch, The Netherlands). The sensitivity of MLPA or RT-MLPA flow-through microarray assay ranged from 10 copies for TOSV, INKV, BATV, and UUKV to 1,000 copies for SFSV, SFNV and TAHV. In most cases, the sensitivity of both methods was comparable.

The authors concluded that combined multiplex MLPA and 3D universal microarray assay is sufficiently sensitive and specific for the detection of European Bunyaviruses and show good correlation to monoplex real-time polymerase chain (RT-PCR) assays. The authors expect that this method can be developed into a diagnostic tool for the rapid analysis of infections due to European Arboviruses. The study was published in ther January 2012 issue of Molecular Biotechnology.

Related Links:

University Medical Center
MRC-Holland
PamGene



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.